A carregar...
Factors associated with guideline-recommended KRAS testing in colorectal cancer patients: A population-based study
OBJECTIVES: Response to epidermal growth factor receptor inhibitors is poorer among Stage IV colorectal cancer (CRC) patients with KRAS mutations, thus KRAS testing is recommended prior to treatment. KRAS testing was collected by Surveillance, Epidemiology, and End Results (SEER) registries for 2010...
Na minha lista:
| Publicado no: | Am J Clin Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4591083/ https://ncbi.nlm.nih.gov/pubmed/25844824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000191 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|